Drugs / levetireacetam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04829838 | Jul 2019 → Jul 2021 | — | ayesha tariq | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | levetireacetam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04829838 ↗ |
| Route | Intravenous | “Intravenous levetireacetam will be given at a loading dose of 20-30mg/kg then it will be added in maintainance dose of (5-30mg/kg/day)” NCT04829838 ↗ |